课题基金 / 基金详情

EPIDEMIOLOGY OF ALZHEIMER DISEASE IN A TOTAL POPULATION

EPIDEMIOLOGY OF ALZHEIMER DISEASE IN A TOTAL POPULATION
总人口中阿尔茨海默病的流行病学
批准号:
3121040
负责人:
DAVID S KNOPMAN
金额:
$41.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-01 至 1995-08-31

项目摘要

项目成果

DAVID S KNOPMAN的其他基金

相似基金

相关文献

中文摘要
翻译
阿尔茨海默病(AD)的流行病学研究基于大量的
英文摘要
An epidemiologic study of Alzheimer's disease (AD) based on a large population [that of the Saquenay-Lac-Saint-Jean (SLSJ) region of Quebec] with several unique and important features, including a computerized population database and one of the world's largest aluminum refineries, is proposed. The first phase of this study has 5 aims: (1) to validate a key informant ascertainment methodology for identifying cases of AD by means of a prevalence survey of 2 geographic regions in SLSJ; (2) to estimate age- and sex-specific prevalence rates of dementia and AD; (3) to follow prevalent cases in order to confirm diagnoses clinically and through autopsy; (4) to identify a fixed cohort of approximately 1,900 non-demented individuals that will be utilized in incidence, risk factor and survival studies; and (5) to perform a population-based case control study of AD focusing on family history od dementia, education and aluminum as risk factors. A 3-stage procedure will be utilized to identify cases. Stage 1 will provide initial identification of dementia suspects (by a network of key informants in year 1; by population screening in years 2 and 3). At stage 2, suspects will be assessed by specially-trained geriatricians and general practitioners to determine whether they meet DSM-IIIR criteria for dementia. At state 3, individuals considered to have dementia will receive a complete workup to determine the disease responsible for the dementia. Key informants will include both health professionals and lay persons. The prevalence survey will utilize a stratified random sample of 2,000 individuals over 64 identified from the socialized health care registry of Quebec. This sample will be screened, and those individuals who fail the screen will be evaluated in stages 2 and 3 for dementia. Non-demented subjects, who will comprise approximately 95% of the sample, will be re- evaluated and followed for development of dementia. Informants for cases of possible and probable AD and for 2 matched controls drawn from the non- demented population will participate in the case-control study. Other non- demented subjects will be administered the risk factor and family history questionnaires to study risk factors in relation to later development of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
  • 批准号:
    10413831
  • 项目类别:
  • 资助金额:
    $72.06万
  • 财政年份:
    2019
  • 负责人:
    DAVID S KNOPMAN
  • 依托单位:
Clinical Core
  • 批准号:
    10657552
  • 项目类别:
  • 资助金额:
    $72.04万
  • 财政年份:
    2019
  • 负责人:
    DAVID S KNOPMAN
  • 依托单位:
Clinical Core
  • 批准号:
    8676247
  • 项目类别:
  • 资助金额:
    $55.11万
  • 财政年份:
    2014
  • 负责人:
    DAVID S KNOPMAN
  • 依托单位:
Frontotemporal degeneration: a basis for clinical trials
  • 批准号:
    6804413
  • 项目类别:
  • 资助金额:
    $39.74万
  • 财政年份:
    2003
  • 负责人:
    DAVID S KNOPMAN
  • 依托单位:
国内基金
海外基金
Aluminum/CFRP 混合管界面分层对渐进折叠机制影响研究
  • 批准号:
    ZCLQN26E0501
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    沈勇
  • 依托单位: